Literature DB >> 19299281

Managing mycetomas.

Mahreen Ameen1.   

Abstract

Mycetomas are chronic, granulomatous, subcutaneous infections caused by traumatic inoculation into the skin of either the actinomycetes bacteria or the eumycetes fungi, giving rise to actinomycetomas and eumycetomas, respectively. They are endemic in the tropics afflicting mainly those of low socio-economic status and men working in agriculture. The disease is slowly progressive and can cause bone involvement, which can result in considerable disability. Late presentation is not uncommon making them notoriously difficult to manage. This article highlights the important aspects of their management and developments in drug therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299281     DOI: 10.1258/td.2008.080151

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  1,10-phenanthroline inhibits the metallopeptidase secreted by Phialophora verrucosa and modulates its growth, morphology and differentiation.

Authors:  Marcela Queiroz Granato; Priscila de Araújo Massapust; Sonia Rozental; Celuta Sales Alviano; André Luis Souza dos Santos; Lucimar Ferreira Kneipp
Journal:  Mycopathologia       Date:  2014-12-12       Impact factor: 2.574

Review 2.  Mycetoma: a clinical dilemma in resource limited settings.

Authors:  Pembi Emmanuel; Shyam Prakash Dumre; Stephen John; Juntra Karbwang; Kenji Hirayama
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-08-10       Impact factor: 3.944

3.  Mycetomas: The Experience of the Dermatology Unit of the University of Milan.

Authors:  Gianluca Nazzaro; Stefano Veraldi
Journal:  Dermatopathology (Basel)       Date:  2018-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.